Saxenda- DK (Liraglutide PFS) 6mg/ml x 3ml

Saxenda (liraglutide) 6mg/ml PFS is a prescription injectable pen for chronic weight management. This 3ml pre-filled syringe pack (3 pens) supports consistent dosing for adults with obesity or weight-related conditions. Store refrigerated between 2-8°C to maintain potency.

Strength

6mg/ml x 3ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Novo Nordisk

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Liraglutide is used for chronic weight management in adults with obesity or overweight with weight-related conditions. It works alongside diet and exercise to support weight loss goals. People often ask, 'what is liraglutide used for' to address long-term weight management needs. It is not a quick fix but part of a broader health plan.

Side Effects

Liraglutide helps reduce appetite and increase feelings of fullness, which may lead to gradual weight loss over time. Users often report reduced cravings and more controlled eating habits. Effects vary by individual and are most noticeable with consistent use and lifestyle adjustments.

Precautions & Warnings

Store liraglutide pens refrigerated between 2-8°C and protect from light. Do not freeze or use if frozen. Keep pens in their original packaging until use. Always check the pen for damage or discoloration before injecting. Dispose of used pens safely according to local regulations.

Avoid Interactions

Liraglutide may interact with other medications, especially those that affect blood sugar or digestion. Alcohol can increase the risk of side effects like nausea. Always inform your healthcare provider about all medications and supplements you are taking. Monitor for unusual symptoms when starting or changing doses.

References

Frequently Asked Questions

Weight loss effects are gradual and typically noticeable within a few weeks of consistent use. Individual results vary based on diet, exercise, and adherence to the treatment plan.

Liraglutide is not approved for diabetes management. It is specifically indicated for chronic weight management in adults with obesity or overweight with weight-related conditions.

If a dose is missed, take it as soon as remembered unless it is close to the next scheduled dose. Do not take two doses at once to catch up.

Liraglutide is not recommended during pregnancy. Consult a healthcare provider for guidance on weight management options if pregnant or planning pregnancy.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.